<?xml version="1.0" encoding="UTF-8"?>
<ref id="B166-pharmaceutics-12-00688">
 <label>166.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mollinedo</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>de la Iglesia-Vicente</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Gajate</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Estella-Hermoso de Mendoza</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Villa-Pulgarin</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Campanero</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Blanco-Prieto</surname>
    <given-names>M.J.</given-names>
   </name>
  </person-group>
  <article-title>Lipid raft-targeted therapy in multiple myeloma</article-title>
  <source>Oncogene</source>
  <year>2010</year>
  <volume>29</volume>
  <fpage>3748</fpage>
  <lpage>3757</lpage>
  <pub-id pub-id-type="doi">10.1038/onc.2010.131</pub-id>
  <?supplied-pmid 20418917?>
  <pub-id pub-id-type="pmid">20418917</pub-id>
 </element-citation>
</ref>
